Altimmune plans Phase 2 trials in 2025 for pemvidutide in alcohol use disorder and liver disease, highlighting weight loss and liver health benefits.

Economists around the world expect muted U.S. economic growth in the coming quarters, and some indicators have shown an increased likelihood of a 2025 recession in recent weeks. [ Sign up for ...

The major indexes suffered another week of sharp losses as Trump tariffs ramped up, shrugging off tame inflation.

The late TV doctor’s wife Dr Clare Bailey Mosley is also bringing out a cookbook titled Eating Together: A Recipe For ...

When you or your bed partner has sleep apnea, a restful night’s sleep can be hard to come by. Treating this common condition ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now soon they may be unavailable to most.

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

RuPaul’s Drag Race alum Peppermint revealed that she’s lost 100 lbs. with the help of weight-loss injections. The 45-year-old ...

A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the ...